GSK 20F 2004 Annual report | GSK Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Abbott, abdominal, abnormal, Abrika, absorb, absorbing, academia, Academy, accurate, accurately, acetylcholine, add, adefovir, AlbugonTM, albumin, Anchen, anchor, angina, Antibacterial, appellate, arguing, Arixtra, arterial, artery, Arthur, artificially, Ashe, Asian, aspartyl, aspartyle, atrial, autism, Avandaryl, Bain, Bangladesh, Beeyar, Berlin, biotech, Biovail, blackcurrant, blood, Boniva, box, Breakthrough, briefly, BV, Canadian, Caribbean, Carnegie, Cervarix, chairmanship, Chamber, chargeback, chewable, Chongqing, Citizenship, civic, Club, Cobalt, Colombia, Commerce, commonplace, concealed, congestive, conspired, contradictory, convalescing, Cor, coronary, Cystic, dampened, DEBRA, decentralised, decertified, deep, Deryck, detriment, diabetic, dipositive, disapply, disgorgement, disposition, Diversa, dyspepsia, ED, Egypt, EITF, Elan, elevation, embarking, embolism, Empowerment, Encouragingly, enquiry, Entereg, entertainment, epidemic, Epizcom, epoprostenol, Epzicom, ESOP, Euclid, evolution, exemplary, fabric, FAS, fastest, feedback, felt, ffinancial, fibrillation, fit, Fluarix, fondaparinux, forefront, fracture, Fraxiparine, Fraxodi, fuelled, fusion, gastrointestinal, gauge, GDP, Genome, Gent, geography, GI, giver, gladly, GlaxoSmithKlinee, globalised, glycoprotein, GP, Grand, gratitude, grocery, Guernsey, Hakluyt, handling, harmonisation, harmonise, harnessed, heparin, Heslop, HFA, hip, histamine, HPV, HSBC, hundred, Hydroactive, hydroxytryptamine, IAS, IASB, IBNR, IFRIC, Ilaclari, immersed, incontinence, infarction, inflationary, inquired, inquiry, Integrilin, intercompany, intercontinental, invention, irrespective, Janssen, jurisdiction, justly, Kaisha, Kivexa, knee, knew, lack, language, lapatinib, Lapdap, Lee, Lehman, lie, Lincoln, linkage, liver, logging, LP, Luxembourg, Maughan, Meiji, Mencevax, metoprolol, Metropolitan, MHRA, MICE, Millennium, misrepresented, modest, Motor, Multidisciplinary, myocardial, narrowed, neurodegenerative, Neurone, NiKem, NYU, occasion, offest, oil, opposed, OptiLead, orlistat, orthopedic, pace, paired, Parsippany, Path, pattern, PDP, PerCent, peripheral, pharma, pharmacogenetic, pharmacovigilance, Pharmco, phenotyped, piboserod, pivotal, PLE, Pliva, PMB, poll, precisely, pro, proliferation, prostacyclin, Pty, pyridone, questionnaire, radafaxine, rata, rationale, ready, recalled, recalling, receded, reclassification, regime, rehearing, remeasured, repaid, requisitioned, resumption, retesting, retiree, retrospective, retrospectively, rheumatoid, rid, ropinirole, Rotarix, Salomon, Sanayi, Sanofi, Sante, Sara, schizophrenia, Seika, Seiyaka, seized, Senegal, Setfirst, settlede, shelf, SIC, SID, simplicity, solve, sp, speaker, Sport, stave, substantive, substantively, succeed, Sudan, surgery, swift, synthetic, syrup, talnetant, technique, thromboembolic, Ticaret, tightly, toCoregon, toCoregto, toCoregwere, today, Toyama, Trilateral, tsunami, turning, twenty, Unhedged, unipolar, unlawfully, unstable, unvested, upfront, uplifting, upward, Urban, urinary, USPTO, vast, vehicle, vein, Vendor, verified, Vesicare, vestipitant, vibrant, violence, visual, Vodafone, warning, Wednesday, Weybridge, white, widow, won, WSFE, Xa, Xenical, yearly

GSK (GSK) 20-F2004 FY Annual report (foreign)

Content analysis